Bioreactive allosteric polynucleotides
CA 2275541 A1 · Owner: Yale University · Inventors: Breaker, Ronald R.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Polynucleotides having allosteric properties that modify a function or configuration of the polynucleotide with a chemical effector and/or physical signal are employed primarily as biosensors and/or enzymes for diagnostic and catalytic purposes. In some preferred embodiments the polynucleotides are DNA , enzymes that are used in solution/suspension or attached to a solid support as biosensors to detect the presence or absence of a compound its concentration, or physical change in a sample by observation of self-catalysis. Chemical effectors include organic compounds such as amino acids amino acid , derivatives, peptides, nucleosides nucleotides, steroids, and mixtures of these with …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 18, 1997. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended December 18, 2017.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 18, 2019.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.